Valérie Philippon, Director of Publication Strategy and Management at Vertex
Valérie Philippon is the Director of Publication Strategy and Management at Vertex Pharmaceuticals, a company based in Cambridge, MA that is seeking to transform the way serous diseases are treated. She is responsible for the development and execution of Publication Strategy for Vertex HCV franchise. Valérie has over 15 years of experience in Research, Development, Program & Portfolio Management, Medical Writing and Publication Planning. She received her Ph.D. in Microbiology from the University of Paris, France where she studied the molecular pathogenesis of retroviruses. She continued in research doing a post-doctoral fellowship at Harvard School of Public Health under the direction of Dr Max Essex and studying the role of Vpr and Vpx proteins in HIV and SIV pathogenesis. Following the completion of her fellowship she accepted a scientist position at Therion Biologics where, as a scientist and program manager, she participated in the discovery and development of cancer immunotherapies and was responsible for the company HIV vaccine development. She then joined Idenix Pharmaceuticals as a Medical Writer where her responsibilities extended from helping clinicians and scientists to write abstracts, conference presentations and manuscripts to coordinate publication planning for the company’s HBV, HCV and HIV drug candidates.